Identification of a potent Nrf2 displacement activator among aspirin-containing prodrugs-Reference-Cited by-同舟云学术

Identification of a potent Nrf2 displacement activator among aspirin-containing prodrugs

Published:2021-10 Issue: Volume:149 Page:105148
ISSN:0197-0186
Container-title:Neurochemistry International
language:en
Short-container-title:Neurochemistry International

Author:

Gaisina Irina N.^ORCID,Hushpulian Dmitry M.,Gaisin Arsen M.,Kazakov Eliot H.,Ammal Kaidery Navneet,Ahuja Manuj,Poloznikov Andrey A.,Gazaryan Irina G.,Thatcher Gregory R.J.,Thomas Bobby^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience

Reference22 articles.

1. Distinct Nrf2 signaling mechanisms of fumaric acid esters and their role in neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced experimental Parkinson's-like disease;Ahuja;J. Neurosci.,2016

2. Quinone formation as a chemoprevention strategy for hybrid drugs: balancing cytotoxicity and cytoprotection;Dunlap;Chem. Res. Toxicol.,2007

3. Quinone-induced activation of Keap1/Nrf2 signaling by aspirin prodrugs masquerading as nitric oxide;Dunlap;Chem. Res. Toxicol.,2012

4. Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases;Fao;Ageing Res. Rev.,2019

5. Challenges and limitations of targeting the Keap1-Nrf2 pathway for neurotherapeutics: Bach1 de-repression to the rescue;Hushpulian;Front. Aging Neurosci.,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of prodrugs as drugs of abuse;WIREs Forensic Science;2024-03-19

2. Carltonine-derived compounds for targeted butyrylcholinesterase inhibition;RSC Medicinal Chemistry;2024

3. Nrf2 for a key member of redox regulation: A novel insight against myocardial ischemia and reperfusion injuries;Biomedicine & Pharmacotherapy;2023-12

4. Emerging small molecule inhibitors of Bach1 as therapeutic agents: Rationale, recent advances, and future perspectives;BioEssays;2023-11-02

5. Carltonine-Derived Compounds for Targeted Butyrylcholinesterase Inhibition;2023